Polianna Delfino-Pereira

Polianna Delfino-Pereira

Auto-generated profile, based on publicly available information

Polianna Delfino-Pereira

Department of Internal Medicine, Medical School, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2024 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
MBMaria Aparecida Camargos Bicalho
Maria Aparecida Camargos Bicalho
MAMárlon Juliano Romero Aliberti
Márlon Juliano Romero Aliberti
PDPolianna Delfino-Pereira
Polianna Delfino-Pereira
VCVictor Schulthais Chagas
Victor Schulthais Chagas
PRPatryk Marques da Silva Rosa
Patryk Marques da Silva Rosa
MMMilena Soriano Marcolino
Milena Soriano Marcolino
Background: Although dementia has emerged as an important risk factor for severe SARS-CoV-2 infection, results on COVID-19-related complications and mortality are not consistent. We examined the clinical presentations and outcomes of COVID-19 in a multicentre cohort of in-hospital patients, comparing those with and without dementia. Methods: This retrospective observational study comprises COVID-19 laboratory-confirmed patients aged ≥ 60 years admitted to 38 hospitals from 19 cities in Brazil. Data were obtained from electronic hospital records. A propensity score analysis was used to match patients with and without dementia (up to 3:1) according to age, sex, comorbidities, year, and hospital of admission. Our primary outcome was in-hospital mortality. We also assessed admission to the intensive care unit (ICU), invasive mechanical ventilation (IMV), kidney replacement therapy (KRT), sepsis, nosocomial infection, and thromboembolic events. Results: Among 1,556 patients included in the study, 405 (4.5%) had a diagnosis of dementia and 1,151 were matched controls. When compared to matched controls, patients with dementia had a lower frequency of dyspnoea, cough, myalgia, headache, ageusia, and anosmia; and higher frequency of fever and delirium. They also had a lower frequency of ICU admission (32.7% vs. 47.1%, p < 0.001) and shorter ICU length of stay (7 vs. 9 days, p < 0.026), and a lower frequency of sepsis (17% vs. 24%, p = 0.005), KRT (6.4% vs. 13%, p < 0.001), and IVM (4.6% vs. 9.8%, p = 0.002). There were no differences in hospital mortality between groups. Conclusion: Clinical manifestations of COVID-19 differ between older inpatients with and without dementia. We observed that dementia alone could not explain the higher short-term mortality following severe COVID-19. Therefore, clinicians should consider other risk factors such as acute morbidity severity and baseline frailty when evaluating the prognosis of older adults with dementia hospitalised with COVID-19.

2 September 2022 in BMC Medicine
Verified
Journal Article
Open access
PDF file
FFFlávio de Azevedo Figueiredo
Flávio de Azevedo Figueiredo
LRLucas Emanuel Ferreira Ramos
Lucas Emanuel Ferreira Ramos
RSRafael Tavares Silva
Rafael Tavares Silva
DPDaniela Ponce
Daniela Ponce
RCRafael Lima Rodrigues Carvalho
Rafael Lima Rodrigues Carvalho
MMMilena Soriano Marcolino
Milena Soriano Marcolino
Background: Acute kidney injury (AKI) is frequently associated with COVID-19, and the need for kidney replacement therapy (KRT) is considered an indicator of disease severity. This study aimed to develop a prognostic score for predicting the need for KRT in hospitalised COVID-19 patients, and to assess the incidence of AKI and KRT requirement. Methods: This study is part of a multicentre cohort, the Brazilian COVID-19 Registry. A total of 5212 adult COVID-19 patients were included between March/2020 and September/2020. Variable selection was performed using generalised additive models (GAM), and least absolute shrinkage and selection operator (LASSO) regression was used for score derivation. Accuracy was assessed using the area under the receiver operating characteristic curve (AUC-ROC). Results: The median age of the model-derivation cohort was 59 (IQR 47–70) years, 54.5% were men, 34.3% required ICU admission, 20.9% evolved with AKI, 9.3% required KRT, and 15.1% died during hospitalisation. The temporal validation cohort had similar age, sex, ICU admission, AKI, required KRT distribution and in-hospital mortality. The geographic validation cohort had similar age and sex; however, this cohort had higher rates of ICU admission, AKI, need for KRT and in-hospital mortality. Four predictors of the need for KRT were identified using GAM: need for mechanical ventilation, male sex, higher creatinine at hospital presentation and diabetes. The MMCD score had excellent discrimination in derivation (AUROC 0.929, 95% CI 0.918–0.939) and validation (temporal AUROC 0.927, 95% CI 0.911–0.941; geographic AUROC 0.819, 95% CI 0.792–0.845) cohorts and good overall performance (Brier score: 0.057, 0.056 and 0.122, respectively). The score is implemented in a freely available online risk calculator (https://www.mmcdscore.com/). Conclusions: The use of the MMCD score to predict the need for KRT may assist healthcare workers in identifying hospitalised COVID-19 patients who may require more intensive monitoring, and can be useful for resource allocation.

1 February 2018 in Epilepsy & Behavior
Verified
Journal Article
Closed access
PDPolianna Delfino-Pereira
Polianna Delfino-Pereira
PBPoliana Bertti-Dutra
Poliana Bertti-Dutra
EUEduardo Umeoka
Eduardo Umeoka
JOJosé Antônio Cortes de Oliveira
José Antônio Cortes de Oliveira
VSVictor Rodrigues Santos
Victor Rodrigues Santos
NGNorberto Garcia-Cairasco
Norberto Garcia-Cairasco

4 April 2022 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
SASuélen Santos Alves
Suélen Santos Alves
RSRui Milton Patricio da Silva-Junior
Rui Milton Patricio da Silva-Junior
PDPolianna Delfino-Pereira
Polianna Delfino-Pereira
MPMarilia Gabriella Alves Goulart Pereira
Marilia Gabriella Alves Goulart Pereira
IVIsrael Vasconcelos
Israel Vasconcelos
NGNorberto Garcia-Cairasco
Norberto Garcia-Cairasco

1 March 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
BPBruno Barbosa Miranda de Paiva
Bruno Barbosa Miranda de Paiva
PPPolianna Delfino Pereira
Polianna Delfino Pereira
CAClaudio Moises Valiense de Andrade
Claudio Moises Valiense de Andrade
VGVirginia Mara Reis Gomes
Virginia Mara Reis Gomes
MSMaira Viana Rego Souza-Silva
Maira Viana Rego Souza-Silva
MMMilena Soriano Marcolino
Milena Soriano Marcolino
The majority of early prediction scores and methods to predict COVID-19 mortality are bound by methodological flaws and technological limitations (e.g., the use of a single prediction model). Our aim is to provide a thorough comparative study that tackles those methodological issues, considering multiple techniques to build mortality prediction models, including modern machine learning (neural) algorithms and traditional statistical techniques, as well as meta-learning (ensemble) approaches. This study used a dataset from a multicenter cohort of 10,897 adult Brazilian COVID-19 patients, admitted from March/2020 to November/2021, including patients [median age 60 (interquartile range 48–71), 46% women]. We also proposed new original population-based meta-features that have not been devised in the literature. Stacking has shown to achieve the best results reported in the literature for the death prediction task, improving over previous state-of-the-art by more than 46% in Recall for predicting death, with AUROC 0.826 and MacroF1 of 65.4%. The newly proposed meta-features were highly discriminative of death, but fell short in producing large improvements in final prediction performance, demonstrating that we are possibly on the limits of the prediction capabilities that can be achieved with the current set of ML techniques and (meta-)features. Finally, we investigated how the trained models perform on different hospitals, showing that there are indeed large differences in classifier performance between different hospitals, further making the case that errors are produced by factors that cannot be modeled with the current predictors.

28 October 2024 in JMIR Medical Informatics
Verified
Journal Article
Open access
BPBruno Paiva
Bruno Paiva
MGMarcos André Gonçalves
Marcos André Gonçalves
LRLeonardo Chaves Dutra da Rocha
Leonardo Chaves Dutra da Rocha
MMMilena Soriano Marcolino
Milena Soriano Marcolino
FLFernanda Cristina Barbosa Lana
Fernanda Cristina Barbosa Lana
VMVivian Costa Morais
Vivian Costa Morais
Background: Proper analysis and interpretation of health care data can significantly improve patient outcomes by enhancing services and revealing the impacts of new technologies and treatments. Understanding the substantial impact of temporal shifts in these data is crucial. For example, COVID-19 vaccination initially lowered the mean age of at-risk patients and later changed the characteristics of those who died. This highlights the importance of understanding these shifts for assessing factors that affect patient outcomes. Objective: This study aims to propose detection, initial characterization, and semantic characterization (DIS), a new methodology for analyzing changes in health outcomes and variables over time while discovering contextual changes for outcomes in large volumes of data. Methods: The DIS methodology involves 3 steps: detection, initial characterization, and semantic characterization. Detection uses metrics such as Jensen-Shannon divergence to identify significant data drifts. Initial characterization offers a global analysis of changes in data distribution and predictive feature significance over time. Semantic characterization uses natural language processing–inspired techniques to understand the local context of these changes, helping identify factors driving changes in patient outcomes. By integrating the outcomes from these 3 steps, our results can identify specific factors (eg, interventions and modifications in health care practices) that drive changes in patient outcomes. DIS was applied to the Brazilian COVID-19 Registry and the Medical Information Mart for Intensive Care, version IV (MIMIC-IV) data sets. Results: Our approach allowed us to (1) identify drifts effectively, especially using metrics such as the Jensen-Shannon divergence, and (2) uncover reasons for the decline in overall mortality in both the COVID-19 and MIMIC-IV data sets, as well as changes in the cooccurrence between different diseases and this particular outcome. Factors such as vaccination during the COVID-19 pandemic and reduced iatrogenic events and cancer-related deaths in MIMIC-IV were highlighted. The methodology also pinpointed shifts in patient demographics and disease patterns, providing insights into the evolving health care landscape during the study period. Conclusions: We developed a novel methodology combining machine learning and natural language processing techniques to detect, characterize, and understand temporal shifts in health care data. This understanding can enhance predictive algorithms, improve patient outcomes, and optimize health care resource allocation, ultimately improving the effectiveness of machine learning predictive algorithms applied to health care data. Our methodology can be applied to a variety of scenarios beyond those discussed in this paper.